TNXP Tonix Pharmaceuticals Holding C

$11.87▼ -3.34% Healthcare Other
After hours $11.85▼ -0.18% Sep 11, 7:58 PM ET
Volume 512.4K Avg Volume (10D) 385.3K
Key Metrics & Fundamentals
Market Cap
$203.58M
P/E Ratio
–
Div Yield
–%
52W Range
9.40 - 31.28
% vs 50 MA
-1.94%
% vs 200 MA
-15.44%
RSI-14
40.0
MACD Histogram
-0.2100
Beta (1Y vs SPY)
2.03
Free Cash Flow
-$42.83M
Gross Rev
$13.54M
Gross Profit
$12.84M
EBITDA
-$41.32M
COGS
$703,000
Operating Exp
$54.78M
Operating Income
-$41.94M
EBIT
-$41.94M
Pretax Income
-$40.55M
Net Income
-$40.55M
EPS (Diluted)
-2.44
Price & Volume History
Loading chart…
Recent News
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
MarketBeat · Sep 12, 2026 2:01 AM
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
GlobeNewswire · Sep 8, 2026 11:00 AM
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
Zacks Small Cap Research · Sep 2, 2026 1:38 PM
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 11:00 AM
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline
MarketBeat · Aug 18, 2026 7:01 AM
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 2:44 PM
Tonix Pharmaceuticals Holding Corp (TNXP) (Q2 2026) Earnings Call Highlights: TONMYA Surges ...
GuruFocus.com · Aug 10, 2026 9:01 PM
Tonix Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 10, 2026 4:04 PM
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 5, 2026 11:00 AM
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.
GlobeNewswire · Aug 3, 2026 11:00 AM
Financial Overview - Income Statement Quarterly

See TNXP's money flow as a full page

Social Sentiment
Avg +0.38 · 10 posts
NewsDiscussionTnxp fda anouncement
r/wallstreetbets · Aug 15, 2025
The author expresses a desire to hold or sell based on the FDA announcement, indicating positive sentiment regarding the stock's potential future.
positive +0.60
DiscussionDDIm probably being stupid, right? Theres no way tonix pharmaceutical stock (tnxp) was $1 million per share, right?
r/wallstreetbets · May 27, 2025
The user expresses disbelief at the stock price, suggesting a negative sentiment towards the investment.
negative -0.60
NewsPriceTargetTNXP is up 105% in week
r/wallstreetbets · Jan 28, 2025
The post reports a significant price increase for TNXP, indicating a positive sentiment.
positive +0.60
DDNewsDiscussionTradePriceTarget$TNXP worth a watch tomorrow 🙌🏽
r/StockMarket · Jan 23, 2025
The post expresses optimism regarding TNXP's prospects and potential revenue, driven by the PDUFA date and FDA fast track.
positive +0.70
TradeDiscussionHey guys been a while, ROLLERCOASTER
r/StockMarket · Dec 27, 2024
The author describes significant profits from TNXP shares, indicating a positive sentiment.
positive +0.60
Page 1 of 2 (10 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙